BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Aquagen International, Inc. Completes Acquisition Of Quantum Laboratories, Inc.


10/19/2005 5:11:15 PM

SALT LAKE CITY, May 10 /PRNewswire-FirstCall/ -- Aquagen International, Inc. today announced the acquisition of Quantum Laboratories, a division of Global Bioenergetics Technology, Inc., an international company that builds medical facilities, develops water enriched and bio-remediation products, located in San Ramon, CA, with additional offices in Hawaii, Connecticut and Yucatan, Mexico.

Aquagen International, Inc. today announced that it completed the acquisition of Quantum Laboratories, a division of Global Bioenergetics Technology and now holds the same as a wholly owned subsidiary. Quantum Laboratories has developed water-enriched products, anti-aging products, anti oxidant and a many other natural products.

"We are very happy to finally complete the Quantum Laboratories acquisition and add Quantum Laboratories to our company," said Joanne Clinger, Aquagen's CEO. "Quantum's natural supplements, anti aging and water products are innovative and proprietary and will benefit by combining our stabilized liquid oxygen product, Aquagen(R), to many formulas," said Clinger.

"Quantum is equally enthused about aligning with Aquagen, since it is a public company with the ability to help us improve our product development and capitalize our joint marketing efforts in not only the natural health food and supplement markets but also in many other marketing channels that Aquagen is either currently in or soon will be," said Charles Zaloumis, Quantum's President and CEO.

"Aquagen has an excellent history. It has developed and marketed its products effectively for many years. This gives the company credibility and longevity. Conversely, we, at Global, have gathered strategic partners and joined with health care professionals and scientists in the traditional and complementary health care fields that can assist in testing and providing markets for our combined health care products and supplements," said Zaloumis. "We believe that we can do some great things together in the coming months and years. With our experience in the medical and health care fields and Aquagen's many years in the marketing and product development trenches, our united companies can be a formidable product development and marketing machine," said Zaloumis.

Effective with the acquisition, Quantum Laboratories is a wholly owned subsidiary of Aquagen International, Inc.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Statements in this press release relating to plans, strategies, economic performance and trends, projections of results of specific activities or investments, and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, risk factors inherent in doing business. Forward-looking statements may be identified by terms such as "may," "will," "should," "could," "expects," "plans," "intends," "anticipates," "believes," "estimates," "predicts," "forecasts," "potential," or "continue," or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. The company has no obligation to update these forward-looking statements. "

Aquagen International, Inc.

CONTACT: Wayne Reichmann for Aquagen International, Inc.,+1-801-484-2777



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES